OncoZenge Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Stian Kildal
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
Stian Kildal
less than a year
Tenure
Mr. Stian Kildal is Chief Executive Officer of OncoZenge AB (publ) from September 13, 2023.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Member of Advisory Board | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | 9.14% SEK 3.7m | |
Member of Advisory Board | less than a year | no data | no data | |
Independent Chairman of the Board | less than a year | no data | no data |
0.3yrs
Average Tenure
37yo
Average Age
Experienced Board: ONCOZ's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.